Table 2: Serum conversion to HBsAg in HBsAg-tg mice and in non-transgenic mice
| Dose 3 | Dose 5 | Dose 10 | |||||||||||||||||||
| Mouse | Isotype | Micea | Ab (+) | % | Mice | Ab (+) | % | Mice | Ab (+) | % | |||||||||||
| Tg | IgG1 | 11 | 1 | 9 | 8 | 8 | 100 | 4 | 4 | 100 | |||||||||||
| IgG2a | 11 | 0 | 0 | 8 | 5 | 63 | 4 | 3 | 75 | ||||||||||||
| Ntg | IgG1 | 9 | 9 | 100 | 6 | 6 | 100 | 3 | 3 | 100 | |||||||||||
| IgG2a | 9 | 9 | 100 | 6 | 6 | 100 | 3 | 3 | 100 | ||||||||||||
aAfter the 3th, 5th, and 10th doses, three to four mice were sacrificed and spleen cells isolated for T-cells response evaluation